Food intolerance, food allergy and IgG testing: what does the literature show?
In this article
  1. Adverse reactions to food
  2. IgG and terminology – why is the literature so heterogeneous?
  3. What does food-specific IgG testing measure?
  4. Immunoglobulins – the place of IgG in the antibody response
  5. Antigens – what does the adaptive immune system recognise?
  6. The complement system – a key element of the effector functions of IgG
  7. Symptoms and differential diagnosis of different food sensitivities
  8. Professional position statements on food-specific IgG/IgG4 testing
  9. What does the 2025 literature review say?
  10. Clinical results with total IgG testing
  11. Summary: the position of the FOODTEST.HU Food Intolerance Centre

Author: Viktória Prémus
Functional nutrition adviser

Reviewed by: Dr Károly Krkos
Laboratory medicine specialist

Different mechanisms may underlie complaints associated with eating. Distinguishing food allergy, classical food intolerance and food-specific IgG positivity is therefore fundamental to interpreting the literature. The overview below presents the immunological basics, professional position statements and studies of IgG-based dietary interventions, together with their limitations.

Contents

Adverse reactions to food

Adverse reactions to food form a heterogeneous group of conditions, so the clinical approach is based on identifying the underlying pathomechanism. "Food sensitivity" is not, in itself, a diagnostic category.

As a first step, we distinguish between toxic and non-toxic reactions.

Toxic reactions

Toxic reactions can develop with sufficient exposure, regardless of individual susceptibility. They include, for example, reactions caused by microbial toxins, natural toxins or other harmful substances.

Non-toxic reactions

The development of non-toxic reactions depends on individual susceptibility. Their two main groups are:

  • immune-mediated reactions
  • non-immune-mediated reactions

This differentiation is clinically fundamental, as the same or a similar symptom phenotype may be underpinned by different pathomechanisms requiring different diagnostic and therapeutic strategies.

Immune-mediated reactions

Immune-mediated food reactions can be divided into IgE-mediated and non-IgE-mediated forms and, according to some classifications, forms with a mixed mechanism.

In IgE-mediated food allergy, mast cell and basophil activation mediated by allergen-specific IgE results in rapid mediator release. The reaction typically appears within minutes to hours; it may manifest as urticaria, angioedema, gastrointestinal or respiratory symptoms, or anaphylaxis, among others.

In non-IgE-mediated food allergies, other immunological mechanisms – including cell-mediated ones – predominate. Symptoms are usually more delayed, and in many conditions gastrointestinal manifestations are predominant.

Food allergy is therefore, by definition, an immune-mediated adverse reaction to food; IgE-mediated allergy is only one of its forms.

Non-immune-mediated food reactions

In this group, no specific immunological mechanism can be demonstrated behind the symptoms. Possible pathomechanisms include:

  • enzymatic abnormalities – e.g. lactose intolerance associated with lactase deficiency;
  • pharmacological reactions – reactions to natural or added bioactive components;
  • irritant/mechanical effects;
  • other metabolic or absorption disorders;
  • psychophysiological mechanisms and mechanisms linked to the gut–brain axis, which can modify symptom perception and gastrointestinal function, particularly in functional gastrointestinal disorders.

The presence of a psychophysiological component does not call into question whether the symptoms are real; bidirectional communication between the central, autonomic and enteric nervous systems can substantially influence visceral sensation and motility.

Clinical significance

The temporal relationship between eating a food and the onset of symptoms does not, in itself, identify the pathomechanism.

Abdominal pain, bloating, diarrhoea, nausea or other gastrointestinal symptoms may result from both immune-mediated and non-immune-mediated processes. The aim of the investigation is therefore not merely to identify the suspected trigger food but – where possible – to determine the mechanism of the reaction.

Every food allergy is an adverse reaction to food, but not every adverse food reaction is an allergy.

Food allergy is immune-mediated, whereas the term "food intolerance" is classically used for non-immune-mediated reactions.

This terminological distinction is particularly important before discussing food-specific IgG, because if we assume an IgG-mediated mechanism, it is by definition not appropriate simply to classify it among the classical, non-immune-mediated "intolerances". This is exactly where the debate on the nomenclature and pathomechanism of IgG-specific food reactions begins.

Source: Brandtzaeg P. Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol. 2010;7:380–400. doi:10.1038/nrgastro.2010.80.

IgG and terminology – why is the literature so heterogeneous?

One of the fundamental problems of the literature on food-specific IgG is the lack of a uniform nomenclature. Different terms are used for the same or partly overlapping clinical phenomena, so the name alone is not suitable for identifying the mechanism studied.

In the WAO nomenclature, allergy is a hypersensitivity reaction mediated by an immunological mechanism, which may be IgE-mediated or non-IgE-mediated. In contrast, reactions of non-immunological origin are best treated as a separate category.

The use of the term "intolerance" is not entirely uniform. In his 2015 debate paper, Dreborg proposes that the term "intolerance" be reserved primarily for non-immune-mediated reactions. It is important, however, that this is a debate article, not in itself an official WAO consensus; a paper representing the opposite position was published in the same issue.

What does this mean for interpreting the IgG literature?

The following terms, among others, appear in the literature:

  • IgG-mediated food hypersensitivity
  • IgG-mediated food reactions
  • food-specific IgG positivity/testing
  • food sensitivity
  • delayed food reactions
  • occasionally food intolerance

These cannot automatically be considered synonyms. When interpreting a study, it must therefore always be clarified separately:

what was measured → with which assay → which IgG subclass or total IgG was tested → in which population → with which clinical endpoint → which pathomechanism was assumed?

An "IgG-mediated food reaction", "food sensitivity" and "food-specific IgG positivity" are therefore not identical concepts.

It is particularly important to distinguish:

  1. the laboratory phenomenon: detectable food-specific IgG
  2. the assumed pathomechanism: e.g. an immune complex-mediated process
  3. the clinical entity: a reproducible symptom that can be linked to a given food and an appropriate mechanism.

The three levels do not automatically follow from one another.

Source: Dreborg S. Debates in allergy medicine: food intolerance does not exist. World Allergy Organ J. 2015;8:37. PMID: 26681998.

What does food-specific IgG testing measure?

Food-specific IgG testing determines the level of IgG antibodies in the serum that bind to given food antigens, using an immunoassay such as ELISA.

The FOODTEST test is based on total IgG, meaning it measures the IgG response to a given food, not only the IgG4 subclass. This is an essential difference from IgG4-specific tests, so the results of the two measurement approaches, and the literature relating to them, cannot automatically be treated as equivalent.

The importance of the antigen preparation

The result is fundamentally influenced by the antigen or antigen extract used in the test system. The antigen's:

  • composition and representativeness,
  • method of production and processing,
  • concentration and stability,
  • as well as the analytical performance of the assay

can all determine the IgG reactivity detected.

Food-specific IgG results obtained on two different laboratory platforms are therefore not necessarily directly comparable.

The laboratory result thus primarily shows whether IgG reactivity to the given antigen is detectable in the assay used, and to what extent. Judging whether this is clinically relevant to the given patient's symptoms requires clinical interpretation.

Immunoglobulins – the place of IgG in the antibody response

The immune system produces five main classes of immunoglobulin: IgG, IgA, IgM, IgE and IgD. IgG predominates quantitatively in the serum, representing around 70–80% of all immunoglobulins.

IgG can be divided into four subclasses: IgG1, IgG2, IgG3 and IgG4. Because of structural differences in their Fc region, the subclasses differ in, among other things, their Fcγ receptor binding, complement-activating capacity, half-life and effector functions.

Functional differences between IgG subclasses

Their complement-activating capacity is not the same. (The approximate order of activation of the classical pathway) The relative order of the complement-activating capacity of the immunoglobulin G subclasses:

IgG3 > IgG1 > IgG2 >> IgG4

IgG1 and especially IgG3 are able to bind C1q efficiently and activate the classical complement pathway. The activity of IgG2 is considerably weaker, while IgG4 can practically not be regarded as an effective activator of the classical complement pathway.

IgG4 is an immunologically special subclass. It can rise during chronic or repeated antigen exposure, and in many settings it behaves rather as a regulatory, inflammation-dampening, competitive "blocking" antibody.

During allergen-specific immunotherapy, for example, an increase in allergen-specific IgG4 may be one of the accompanying phenomena of a tolerogenic immune response.

Classification of antibodies in more detail

IgM

The defining antibody of the early phase of the primary humoral immune response. Its secreted form is typically a pentamer, so it has high avidity and activates the classical complement pathway efficiently.

IgG

The dominant immunoglobulin of the serum, with four subclasses: IgG1, IgG2, IgG3 and IgG4. It is the defining component of the secondary humoral immune response; it is involved in, among other things, neutralisation, opsonisation, Fc receptor-mediated effector processes and – depending on the subclass – complement activation. Through placental transport it provides foetal/neonatal passive immunity.

IgG1

The most abundant subclass (~60%). It takes part efficiently in neutralisation, opsonisation and Fcγ receptor-mediated effector processes, and is able to activate the classical complement pathway.

IgG2

It represents about 20–30% of total IgG. It is particularly important in the immune response to polysaccharide antigens. Its complement-activating and Fcγ receptor-mediated effector activity is generally weaker than that of IgG1 and IgG3.

IgG3

Its quantity is relatively low, yet it is an exceptionally strong effector subclass. It binds Fcγ receptors efficiently and, of the IgG subclasses, generally activates the classical complement pathway most strongly. Its half-life is shorter than that of the other IgG subclasses.

IgG4

It represents a small proportion (~4%) of total IgG and differs significantly in function from the other subclasses. It does not activate the classical complement pathway, or does so only minimally, and its effector functions are generally less pro-inflammatory. It can rise with repeated or prolonged antigen exposure and, in many situations, is associated with a tolerogenic/regulatory immune response.

The special feature of IgG4

IgG4 is characterised by so-called Fab-arm exchange, during which molecules can swap half-antibodies. As a result, functionally bispecific antibodies can be formed, which are less able to form large immune complexes and to activate effector systems.

This is particularly relevant when interpreting food-specific IgG:

IgG1/IgG3 → greater effector and complement-activating potential

IgG4 → rather regulatory/tolerogenic character, minimal complement activation

IgA

Two subclasses are known (IgA1, IgA2). It is the defining immunoglobulin of mucosal immunity; its secretory form is found mainly on the gastrointestinal, respiratory and urogenital mucosae. It plays an important role in neutralising pathogens and antigens and in maintaining the mucosal barrier.

IgE

It occurs in very low serum concentrations. It binds with high affinity to the FcεRI receptor of mast cells and basophils; antigen-induced cross-linking results in degranulation and mediator release. It plays a central role in type I hypersensitivity reactions and in the immune response against helminths.

IgD

It is found in minimal amounts in the serum. It is expressed mainly in membrane-bound form on the surface of naive B cells, where, together with IgM, it functions as the B-cell antigen receptor (BCR).

The five immunoglobulin classes therefore differ not merely in quantity: they have different receptors, tissue distributions and effector functions. Moreover, within IgG the individual subclasses do not have the same function either, which is of fundamental importance in distinguishing food-specific total IgG and IgG4 tests.

Antigens – what does the adaptive immune system recognise?

An antigen is a molecule or molecular structure that the adaptive immune system can specifically recognise. B-cell receptors and antibodies can bind to native antigen structures, whereas T cells typically recognise peptides presented by MHC molecules.

From a nutritional point of view, the most important antigens are food proteins and their epitopes. Immunological recognition of a food antigen is, however, a physiological phenomenon in itself: the healthy mucosal immune system maintains oral tolerance to most food antigens.

Not every antigen is a protein

The following can act as antigens:

  • proteins and peptides,
  • polysaccharides,
  • glycoproteins and glycolipids,
  • and other complex molecular structures.

A clinically important example is the α-Gal (galactose-α-1,3-galactose) carbohydrate epitope. Specific IgE against it may underlie α-Gal syndrome, which – unusually compared with IgE-mediated food allergies – can cause a delayed allergic reaction after eating mammalian meat and other mammal-derived products containing α-Gal.

Antigen ≠ allergen

This difference is particularly important for the IgG topic:

Antigen: a structure that can be specifically recognised by the adaptive immune system.

Allergen: an antigen capable of triggering an allergic hypersensitivity reaction.

Consequently, detecting an antibody against a food antigen does not in itself necessarily prove an abnormal immune reaction.

The complement system – a key element of the effector functions of IgG

The complement system is an effector system of innate immunity consisting of more than 30 plasma and membrane proteins. Its activation triggers a proteolytic cascade that amplifies immunological recognition and converts it into effector mechanisms.

Its main functions:

  • promoting opsonisation and phagocytosis – mainly via C3b;
  • activation and chemotaxis of inflammatory cells – via C3a and C5a, among others;
  • membrane damage through formation of the terminal complement complex (C5b–9, MAC);
  • supporting the removal of circulating immune complexes;
  • providing the link between the adaptive and innate immune responses.

Its relationship with IgG

The complement system can be activated via three main pathways: the classical, lectin and alternative pathways. For IgG, the classical pathway is primarily relevant.

Antigen-bound IgM and, in an appropriate spatial arrangement, certain IgG subclasses can activate the classical complement pathway by binding C1q.

Relationship with type III hypersensitivity

In the classical type III hypersensitivity reaction, soluble antigens and antibodies – mainly IgG – form immune complexes.

Normally, the body removes a large proportion of these. A pathological process can develop if the immune complexes persist, are not adequately eliminated and are deposited in tissues. This may be followed by complement activation, Fcγ receptor-mediated leucocyte activation and local inflammatory tissue damage.

The process, in simplified form:

antigen + IgG → immune complex → inadequate clearance/tissue deposition → complement and FcγR activation → inflammation → tissue damage

Antigen–IgG binding can also be a physiological immunological phenomenon. Type III hypersensitivity is defined not by the presence of IgG in itself, but by pathogenic immune complex formation and the effector inflammation it triggers.

Symptoms and differential diagnosis of different food sensitivities

Complaints associated with eating can overlap considerably, while different pathomechanisms may lie behind them. Gastrointestinal symptoms – bloating, abdominal pain, diarrhoea, nausea – are therefore not, on their own, suitable for determining the mechanism of the reaction.

IgE-mediated food allergy

IgE-mediated food allergy is a well-defined immunological condition in which mast cell and basophil activation mediated by allergen-specific IgE underlies the reaction.

Characteristics:

  • rapid onset, usually within minutes to 2 hours;
  • skin and mucosal symptoms: urticaria, pruritus, angioedema;
  • gastrointestinal symptoms: vomiting, abdominal pain, diarrhoea;
  • respiratory and cardiovascular involvement may also occur;
  • in severe cases, anaphylaxis;
  • often even a small amount of antigen can provoke a reaction.

The diagnosis is based not on a positive specific IgE or skin prick test alone, but on the combined evaluation of the medical history and confirmation of sensitisation; where necessary, a controlled oral food challenge.

Enzymatic intolerances

Non-immune-mediated reactions. A classic example is lactose intolerance resulting from lactase deficiency.

Characteristics:

  • mainly gastrointestinal symptoms;
  • bloating, abdominal cramps, diarrhoea;
  • generally dose-dependent;
  • the individual tolerance threshold can vary considerably;
  • there is no allergic sensitisation, and anaphylaxis is not typical.

Here, then, the complaints are caused not by immunological recognition of the food, but by inadequate digestion/absorption of the given component and the resulting luminal processes.

Food-specific IgG reactivity

Terminological precision is particularly important here. Detecting food-specific IgG is not in itself the same as a clinically manifest food sensitivity (intolerance), and it does not define a uniform clinical syndrome in the way IgE-mediated allergy does.

Clinical studies of IgG-associated reactions have mainly examined patient groups with chronic or recurrent, often gastrointestinal, symptoms. The symptoms, however, are non-specific and may overlap considerably with, for example, IBS and other functional gastrointestinal disorders.

Clinical differentiation

In differentiation, the latency, reproducibility and dose-dependence of the symptoms, the organ systems involved, the symptoms, comorbidities and the results of diagnostic tests performed with an appropriate indication should be evaluated together.

Professional position statements on food-specific IgG/IgG4 testing

When assessing IgG-based tests professionally, a fundamental methodological question is whether the position statement in question evaluates food-specific total IgG, IgG4 or both. The two measurements are not equivalent from an immunological point of view.

The 2022 position statement of the Hungarian Dietetic Association (MDOSZ) discusses IgG- and IgG4-based tests together and does not regard their use as a validated diagnostic method for detecting either food allergy or non-immune-mediated food sensitivity (intolerance).

One of the references on which the position statement is based is the EAACI 2008 Task Force Report. Its main subject, however, is the determination of food-specific IgG4. According to the EAACI position, food-specific IgG4 is frequently detectable in healthy individuals too, may primarily be a physiological consequence of repeated antigen exposure, and may also be associated with tolerance. Accordingly, determination of food-specific IgG4 is not recommended for the diagnosis of food allergy or food intolerance.

Total IgG ≠ IgG4

This distinction is essential in interpreting the literature.

Total food-specific IgG testing measures the IgG response to the given food antigen, to which the IgG1, IgG2, IgG3 and IgG4 subclasses may contribute to differing degrees. An IgG4-specific test, by contrast, examines only a single, functionally distinctive subclass.

Consequently, evidence relating to IgG4 cannot automatically be regarded as evidence relating to total IgG.

This does not, however, mean that the clinical validity of total IgG tests has been demonstrated. It simply means that the clinical usefulness of total IgG must be judged directly on the basis of studies measuring total IgG.

What can be considered consensus?

Two questions can be separated relatively clearly.

1. IgE-mediated food allergy

Food-specific IgG or IgG4 cannot be used for allergy diagnostics and is not suitable for confirming or ruling out IgE-mediated food allergy. Its investigation is based on the clinical history, specific IgE tests/skin prick tests and, where indicated, an oral food challenge.

2. Non-immune-mediated intolerances

Enzymatic or other non-immune-mediated intolerances – for example lactose intolerance associated with lactase deficiency – likewise cannot be diagnosed on the basis of food-specific IgG, since a specific humoral immune response is not central to their pathomechanism.

So where is the real scientific debate?

The relevant question is not:

"Can IgE-mediated food allergy or enzymatic intolerance be diagnosed with an IgG test?"

No. That is not what the test is for.

The scientifically relevant question is narrower:

"Is there a clinically meaningful association between the food-specific total IgG pattern and certain chronic symptom complexes, and does an elimination–reintroduction intervention guided by IgG results improve clinical outcomes in an appropriately selected patient population?"

Answering this requires more than position statements rejecting the diagnostic use of IgG4, but the detection of food-specific total IgG does not in itself prove pathogenicity either.

A proper evaluation of the evidence requires separate examination of:

analytical validity → clinical association → clinical validity → clinical usefulness.

The last question is particularly important: does an IgG-guided dietary intervention deliver better clinical results than a control, sham or standard dietary approach?

A negative position statement on IgG4 is therefore not the same as proof that total IgG is clinically irrelevant. At the same time, total IgG positivity cannot in itself be regarded as a disease marker or as causal evidence.

To judge clinical significance, the analyte in question – total IgG or an IgG subclass –, the patient population, the clinical endpoint and, above all, the effectiveness of the IgG-guided intervention must therefore be evaluated separately.

Source: Stapel SO, Asero R, Ballmer-Weber BK, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. 2008;63(7):793–796. PMID: 18489614.

What does the 2025 literature review say?

The narrative review published in 2025 by Garmendia, De Sanctis and García draws attention to one of the fundamental problems concerning the clinical significance of food-specific IgG antibodies: the same laboratory phenomenon can have different meanings in different biological contexts.

The authors reviewed the literature available up to March 2025, including the immunological role of food-specific IgG, studies in different patient populations, IgG-based elimination interventions and professional recommendations.

1. Food-specific IgG is not in itself a disease marker

Food-specific IgG antibodies can also be detected in healthy individuals, so their mere presence does not prove food-induced disease or clinically relevant hypersensitivity.

It is particularly important to distinguish IgG4, which may be associated with repeated antigen exposure and immunological tolerance. This explains why the presence of food-specific IgG4 alone is not suitable for diagnosing food allergy or food intolerance.

2. In certain diseases, however, different IgG patterns can be observed

The review also summarises studies that described an elevated or altered food-specific IgG response in, among others:

  • irritable bowel syndrome (IBS),
  • inflammatory bowel diseases (IBD),
  • coeliac disease,
  • and other conditions associated with intestinal inflammation or increased barrier permeability.

3. The results of IgG-based elimination diets are noteworthy but cannot be regarded as definitive evidence

The authors discuss several clinical studies in which symptom improvement was observed with an elimination diet compiled on the basis of food-specific IgG.

The clinical evidence, however, is heterogeneous. There are significant differences between studies in terms of patient population, test used, IgG subclasses measured, positivity thresholds (cut-off values), duration of elimination and clinical endpoints.

The results so far therefore represent a clinically interesting hypothesis and a potential area of therapeutic application, but they are not yet sufficient for food-specific IgG testing to become a general population screening test or a stand-alone diagnostic test.

4. The key question, then, is not whether IgG testing can be used.

Three separate questions need to be asked:

  1. Can food-specific IgG be detected? → Yes, in healthy individuals too.
  2. Does a positive IgG in itself prove the pathogenicity of a given food? → No.
  3. Can the food-specific IgG pattern help to design a targeted elimination intervention in defined patient groups? → Convincing, positive clinical data on this have already been published, which we review below.

Source: Garmendia JV, De Sanctis JB, García AH. Food-Specific IgG Antibodies: Decoding Their Dual Role in Immune Tolerance and Food Intolerance. Immuno. 2025;5(3):25. DOI: 10.3390/immuno5030025.

Clinical results with total IgG testing

Based on the review by Garmendia et al. and on other studies

Irritable bowel syndrome (IBS)

Atkinson et al. (2004): randomised controlled IBS trial

Atkinson and colleagues examined the effectiveness of a dietary intervention that involved eliminating all foods to which patients with IBS showed elevated IgG antibody levels. This intervention was compared with a sham diet that excluded the same number of foods, but not those to which the patients showed a specific antibody response. The results showed that, after 12 weeks, the true dietary intervention reduced symptom scores by 10% more than the sham diet ( p = 0.024).

Source: Atkinson, W.; Sheldon, T.A.; Shaath, N.; Whorwell, P.J. Food elimination based on IgG antibodies in irritable bowel syndrome: A randomised controlled trial. Gut 2004, 53, 1459–1464.

Drisko et al. (2006): elimination, food challenge and probiotics

Drisko and colleagues showed that a diet tailored to IgG responses to food and mould panels significantly improved symptoms and quality of life in 20 IBS patients whose symptoms had not improved with standard medical treatment.

Source: Drisko, J.; Bischoff, B.; Hall, M.; McCallum, R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J. Am. Coll. Nutr. 2006, 25, 514–522.

Ostrowska et al. (2021): comparison of three dietary approaches

An open-label study involving 73 female patients compared the effectiveness of three different dietary treatment plans (a low-FODMAP diet, an IgG-based elimination-rotation diet and a control diet recommended by the treating physician) in patients with mixed IBS. In the group following the IgG-based elimination-rotation diet, the symptoms of IBS and of comorbidities improved significantly or disappeared completely. This diet proved more effective than the low-FODMAP and control diets.

Source: Ostrowska, L.; Wasiluk, D.; Lieners, C.F.J.; Gałęcka, M.; Bartnicka, A.; Tveiten, D. Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS-Results from an Open Label Study. J. Clin. Med. 2021, 10, 4317.

Guo et al. (2012): diarrhoea-predominant IBS

In a study involving 77 patients with diarrhoea-predominant IBS (IBS-D) and 26 healthy controls, specific IgG antibodies to 14 common foods were measured. Food-specific IgG positivity was detected in 50.65% of IBS-D patients, but in only 15.38% of controls. Of the IgG-positive patients, 35 avoided the foods with positive results for 12 weeks. After just 4 weeks most IBS symptoms had improved, and after 12 weeks there was a significant reduction in, among other things, abdominal pain and bloating, frequency of diarrhoea, abdominal discomfort and the overall symptom score (9.06 → 3.6).

Source: Guo H, Jiang T, Wang J, Chang Y, Guo H, Zhang W. The value of eliminating foods according to food-specific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea. J Int Med Res. 2012;40(1):204–210. DOI: 10.1177/147323001204000121. PMID: 22429360.

Singh et al. (2025): multicentre, sham-controlled trial

In a randomised, double-blind, sham-controlled trial conducted at 8 centres, 238 patients with IBS were randomised to an 8-week elimination diet guided by food-specific IgG results or to a sham elimination diet. 223 patients were included in the modified intention-to-treat analysis. Those following the IgG-guided diet achieved the primary endpoint – a reduction of at least 30% in abdominal pain intensity – in a significantly higher proportion than those on the sham diet (59.6% vs. 42.1%; p=0.02). The effect was particularly pronounced in IBS-C (67.1% vs. 35.8%) and IBS-M (66.0% vs. 29.5%). Based on the results, the authors regard a personalised elimination diet guided by an appropriate IgG test as a promising therapeutic approach.

Source: Singh P, Chey WD, Takakura W, et al. A Novel, IBS-Specific IgG ELISA-Based Elimination Diet in Irritable Bowel Syndrome: A Randomized, Sham-Controlled Trial. Gastroenterology. 2025;168(6):1128–1136.e4. DOI: 10.1053/j.gastro.2025.01.223. PMID: 39894284.

Hernando et al. (2026): review of 13 intervention studies

A systematic review published in 2026 evaluated data from 13 intervention studies with a total of 935 IBS patients diagnosed according to the Rome criteria. Overall, IgG-based elimination diets were associated with an improvement in gastrointestinal symptoms – including abdominal pain, bloating, bowel habits and stool consistency – and with a better quality of life. Some studies also reported improvement in extraintestinal symptoms such as migraine, anxiety and fatigue.

Source: Hernando A, Morais Costa B, Charneca S, Santos I, Sousa Guerreiro C. Mapping the Evidence on IgG-Based Elimination Diets for the Management of Irritable Bowel Syndrome in Adults: A Systematic Scoping Review. Nutrition Reviews. 2026; nuaf268. DOI: 10.1093/nutrit/nuaf268. PMID: 41578453.

Inflammatory bowel diseases (IBD)

Cai et al. (2014): IgG reactivity in inflammatory bowel diseases

In their study, Cai and colleagues detected food-specific IgG antibodies in 75.9% of patients with Crohn's disease (60 of 79) and 63.6% of patients with ulcerative colitis (21 of 33), compared with 33.1% of healthy controls (88 of 266).

Source: Cai, C.; Shen, J.; Zhao, D.; Qiao, Y.; Xu, A.; Jin, S.; Ran, Z.; Zheng, Q. Serological investigation of food specific immunoglobulin G antibodies in patients with inflammatory bowel diseases. PLoS ONE 2014, 9, e112154.

The Bentz and Wang research groups: dietary intervention and IgG patterns

They showed that a diet designed around these IgG antibodies reduced daily stool frequency compared with the control group. Furthermore, Wang and colleagues showed that, on a panel of 14 foods, the food-specific IgG positivity rate reached 90.72% in patients with Crohn's disease, compared with 57.5% in patients with ulcerative colitis and 42% in the healthy control group. While there were significant differences between patients with Crohn's disease and the control group, no such difference was found between patients with ulcerative colitis and the control group. A larger number of IgG-positive foods was found in patients with both Crohn's disease and ulcerative colitis compared with the control group.

Sources: Bentz, S.; Hausmann, M.; Piberger, H.; Kellermeier, S.; Paul, S.; Held, L.; Falk, W.; Obermeier, F.; Fried, M.; Schölmerich, J.; et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: A double-blind cross-over diet intervention study. Digestion 2010, 81, 252–264. and Wang, H.Y.; Li, Y.; Li, J.J.; Jiao, C.H.; Zhao, X.J.; Li, X.T.; Lu, M.J.; Mao, X.Q.; Zhang, H.J. Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease. World J. Clin. Cases 2019, 7, 2189–2203.

Liu et al. (2018): six-month study in ulcerative colitis

In a 6-month prospective study involving 97 patients with ulcerative colitis, participants were randomised to an elimination diet compiled on the basis of IgG results (n=49) or to a healthy control diet (n=48). Food-specific IgG antibodies were detected in 70.1% of patients. At the end of the 6-month intervention, the Mayo score of the IgG-guided elimination group was significantly lower than that of the control group (2.41 ± 0.89 vs. 3.52 ± 1.15; p<0.05); in addition, quality of life improved, and more favourable BMI and albumin values were measured. According to the study, the IgG-guided elimination diet was associated with a clinical benefit in ulcerative colitis.

Source: Liu J, He A, Liu G, et al. Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study. Inflamm Bowel Dis. 2018;24(9):1918–1925. DOI: 10.1093/ibd/izy110. PMID: 29788288.

Bentz et al. (2010): double-blind, cross-over Crohn's study

In a double-blind, cross-over study, the food-specific IgG levels of 79 patients with Crohn's disease and 20 healthy controls were compared, and then, in 40 patients with Crohn's disease, an elimination diet based on IgG results was examined against a sham diet in a double-blind, cross-over intervention. The food-specific IgG pattern of the Crohn's patients differed significantly from that of the healthy controls. During the IgG-based diet, daily stool frequency fell significantly, by 11%, compared with the sham diet; in addition, abdominal pain decreased and general well-being improved. According to the authors, the nutritional intervention based on food-specific IgG showed a clinical effect in Crohn's disease.

Source: Bentz S, Hausmann M, Piberger H, et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: a double-blind cross-over diet intervention study. Digestion. 2010;81(4):252–264. DOI: 10.1159/000264649. PMID: 20130407.

Atopic dermatitis and eczema

Germano et al. (1993): antibody response in atopic dermatitis

In a cohort of twenty-one children diagnosed with atopic dermatitis, levels of ovalbumin-specific IgG and α-lactalbumin-specific IgA were significantly higher than in a control group of fifteen healthy children.

Source: Germano, P.; Pezzini, A.; Boccagni, P.; Zanoni, G.; Tridente, G. Specific humoral response to cows’ milk proteins and ovalbumin in children with atopic dermatitis. Int. J. Clin. Lab. Res. 1993, 23, 206–211.

Liu et al. (2018): childhood eczema and IgG levels

Furthermore, a study by Liu and colleagues showed that the rate of food-specific IgG was 91.4% in the eczema group ( n = 140) and 93.4% in the allergy group ( n = 76). These rates were significantly higher than those observed in the control group of healthy children.

Source: Liu, Y.; Yan, H.; Shao, F.; Li, Q.H.; Cui, M. Correlation between childhood eczema and specific IgG antibody level. J. Biol. Regul. Homeost. Agents 2018, 32, 341–344

Relationship with allergy

Atwah and Koshak (2024): retrospective paediatric study

In the retrospective study by Fahad Atwah and Abdulqader Koshak (2024), all 75 children and adolescents with allergic disorders – including atopic dermatitis, food allergy, allergic rhinitis and asthma – had positive food-specific IgG results. Dairy products, gluten and egg were the most frequently detected antigens. These results suggest a possible link between diet and immune activation in childhood allergy. Although the clinical significance of IgG remains debated, its constant presence cannot be ignored. Further research is needed to explore its relationship with diet and the gut microbiota.

Source: Atwah, A.F.; Koshak, E.A. Exploring food-specific IgG responses in pediatric allergic disorders: A retrospective cross-sectional study. Allergol. Immunopathol. 2024, 52, 85–90.

Autism

Youssef et al. (2021): food-specific antibodies in ASD

In the study by Youssef and colleagues, the authors evaluated IgG-mediated food intolerance in children diagnosed with ASD. The study observed a high prevalence of elevated IgG antibody levels to common dietary proteins, including casein, gluten and soya, in the cohort diagnosed with ASD. These immune responses were interpreted as potential indicators of immune dysregulation or altered intestinal permeability. The researchers hypothesised that such immune responses may play a role in the manifestation or worsening of the gastrointestinal and behavioural symptoms frequently observed in children with autism.

At the same time, they acknowledged that the clinical implications of IgG seropositivity are still unclear and stressed that more controlled studies would be needed to confirm a causal or diagnostic role.

Source: Youssef, G.; Kazim, K.; Hattawi, H. Food Intolerance In Children with Autism Spectrum Disorders. Egypt. J. Ear Nose Throat Allied Sci. 2021, 22, 1–7.

De Magistris et al. (2013): antibodies and intestinal permeability

Building on this line of research, de Magistris and colleagues carried out a comprehensive analysis of serum IgG antibody levels against various food antigens in individuals with autism spectrum disorder (ASD), and evaluated intestinal permeability and markers of immune activation. Their study showed significantly higher IgG titres against gliadin, casein and other dietary proteins in the ASD group compared with neurotypical controls. Importantly, this rise in IgG levels was accompanied by signs of impaired intestinal barrier function ("leaky gut"), suggesting a possible link between intestinal hyperpermeability and systemic immune sensitisation to food antigens. The authors hypothesised that this immune-gastrointestinal dysfunction may play a role in the pathophysiology of autism in certain subgroups of patients, particularly those with comorbid gastrointestinal symptoms or chronic inflammation.

Source: de Magistris, L.; Picardi, A.; Siniscalco, D.; Riccio, M.P.; Sapone, A.; Cariello, R.; Abbadessa, S.; Medici, N.; Lammers, K.M.; Schiraldi, C.; et al. Antibodies against food antigens in patients with autistic spectrum disorders. BioMed Res. Int. 2013, 2013, 729349. and Xu, G.; Snetselaar, L.G.; Jing, J.; Liu, B.; Strathearn, L.; Bao, W. Association of Food Allergy and Other Allergic Conditions with Autism Spectrum Disorder in Children. JAMA Netw. Open 2018, 1, e180279.

Migraine

Zhao et al. (2024): migraine and associated symptoms

Zhao and colleagues examined differences in headache and comorbidity symptoms in 129 migraine patients with food-specific IgG antibodies. Migraine patients positive for food-specific IgG antibodies had significantly worse headache, gastrointestinal and anxiety symptoms than patients with negative IgG antibody levels. The most common positive foods were egg, milk, shrimp, cod, crab, maize and chicken.

Source: Zhao, Z.M.; Yang, M.M.; Zhao, X.S.; Wan, F.J.; Ning, B.L.; Zhang, L.M.; Fu, J. The Impact of Food Specific IgG Antibodies on Migraine and Its Comorbidities. Immun. Inflamm. Dis. 2024, 12, e70056.

Alpay et al. (2010): randomised, cross-over migraine trial

In the (randomised, double-blind, cross-over) trial by Alpay and colleagues, dietary restriction based on IgG antibodies against 266 food antigens was an effective strategy for reducing the frequency of migraine attacks and average medication intake.

Source: Alpay, K.; Ertas, M.; Orhan, E.K.; Ustay, D.K.; Lieners, C.; Baykan, B. Diet restriction in migraine, based on IgG against foods: A clinical double-masked, randomised, cross-over trial. Cephalalgia 2010, 30, 829–837.

Rees et al. (2005): follow-up of migraine patients

Rees and colleagues showed that 60 of 61 migraine patients (98.4%) had a positive IgG test to a total of 48 different foods, with an average of 5.3 (range 0–17) reactions per patient. After two months of excluding the positive foods, 38.2% of patients reported significant improvement.

Source: Rees, T.; Watson, D.; Lipscombe, S.; Speight, H.; Cousins, P.; Hardman, G.; Dowson, A. A prospective audit of food intolerance among migraine patients in primary care clinical practice. Headache Care 2005, 2, 105–110.

Arroyave Hernández et al. (2007): migraine and food-specific IgG

Similarly, Arroyave Hernández and colleagues evaluated IgG to 108 foods in 56 patients with migraine resistant to conventional treatment. The number of IgG-positive food results was significantly higher in migraine patients than in the 56 controls. IgG-based elimination diets controlled migraine even without medication.

Source: Arroyave Hernández, C.M.; Echavarría Pinto, M.; Hernández Montiel, H.L. Food allergy mediated by IgG antibodies is associated with migraine in adults. Rev. Alerg. Mex. 2007, 54, 162–168.

Aydinlar et al. (2013): coexisting migraine and IBS

Aydinlar and colleagues evaluated the therapeutic potential of an IgG-based elimination diet in patients with IBS and migraine. In a double-blind, randomised, controlled, cross-over clinical trial, IgG antibody tests against 270 foods were performed in 21 patients. The elimination diet was associated with a significant reduction in the number of migraine attacks, maximum attack duration, average attack duration, maximum attack severity, the number of attacks requiring acute medication, and the severity of pain and bloating.

Source: Aydinlar, E.I.; Dikmen, P.Y.; Tiftikci, A.; Saruc, M.; Aksu, M.; Gunsoy, H.G.; Tozun, N. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache 2013, 53, 514–525.

Zhao et al. (2026): pilot dietary intervention and the microbiome

A 12-week pilot intervention study published in 2026 examined 98 migraine patients with at least one food-specific IgG positivity: 52 patients eliminated their IgG-positive foods, while 46 controls followed a sham diet in which IgG-negative foods were excluded. IgG-guided elimination led to significant positive changes in the diversity and composition of the gut microbiome, including an increase in the relative abundance of Bifidobacterium and Butyricicoccus. In the true elimination group, zonulin levels fell more than in the sham group, and some microbiome changes were associated with reductions in zonulin, IL-6 and CGRP, as well as with clinical measures related to migraine and sleep quality. According to the results, IgG-guided elimination in migraine patients may be associated not only with symptom improvement but also with changes in the gut microbiome and in biomarkers related to the intestinal barrier; however, as this is a pilot study, further, larger studies are needed to confirm the results.

Source: Zhao Z-M, Wan F-J, Yang M-M, Ning B-L, Song T, Fu J. IgG positive food elimination diet altered gut microbiota, decreased zonulin in migraine adults: a pilot dietary intervention trial. Frontiers in Nutrition. 2026;13:1878772. DOI: 10.3389/fnut.2026.1878772. PMID: 42656533.

Obesity and cardiovascular disease

Wilders-Truschnig et al. (2008): inflammatory and vascular wall markers

Wilders-Truschnig and colleagues evaluated anti-food IgG levels in 30 obese juvenile patients and compared them with non-obese juveniles.

They found that the intima-media thickness of the carotid arteries, C-reactive protein values and anti-food IgG antibody concentrations were significantly increased in obese young people compared with juveniles of normal weight. Anti-food IgG also correlated with C-reactive protein and intima-media thickness.

Source: Wilders-Truschnig, M.; Mangge, H.; Lieners, C.; Gruber, H.; Mayer, C.; März, W. IgG antibodies against food antigens are correlated with inflammation and intima media thickness in obese juveniles. Exp. Clin. Endocrinol. Diabetes 2008, 116, 241–245.

Yaman Onmus et al. (2016): body weight and metabolic parameters

In a randomised study involving 82 overweight or obese adults (BMI ≥25 kg/m²) who had not responded adequately to previous weight-loss diets, an elimination diet based on a food-specific IgG test (n=42) was compared with a personalised weight-loss control diet (n=40) over 6 months. In the IgG-guided group, a significantly greater reduction in body weight, BMI and body fat, as well as a more favourable waist-to-hip ratio, was observed; body weight fell on average from 86.60 kg to 77.99 kg, compared with 89.60 kg to 88.69 kg in the control group. Triglyceride levels also changed more favourably in the elimination group, while there was no significant difference between the groups in fasting blood glucose, HbA1c or cholesterol values. The study indicated a possible weight and metabolic benefit of IgG-guided elimination in this selected population.

Source: Yaman Onmus M, Cakirca Avcu E, Saklamaz A. The Effect of Elimination Diet on Weight and Metabolic Parameters of Overweight or Obese Patients Who Have Food Intolerance. Journal of Food and Nutrition Research. 2016;4(1):1–5. DOI: 10.12691/jfnr-4-1-1.

Autoimmunity

Coucke (2018): observational study in autoimmune diseases

One study compared 100 patients with autoimmune diseases with 25 controls without autoimmunity. IgG levels of specific food antibodies were significantly higher in the patient group than in the control group. The most reactive foods were casein, cow's milk, wheat, gliadin, egg white and rice. The author suggested that a diet based on IgG results may be useful for patients of this kind.

Source: Coucke, F. Food intolerance in patients with manifest autoimmunity. Observational study. Autoimmun. Rev. 2018, 17, 1078–1080.

Psychiatric disorders

Karakula-Juchnowicz et al. (2018): major depressive disorder

In patients with major depressive disorder (n = 22), serum IgG levels against 39 selected food antigens were determined. IgG food hyperreactivity was detected in 64% of patients, compared with 19% of the healthy control group ( n = 21).

Source: Karakula-Juchnowicz, H.; Gałęcka, M.; Rog, J.; Bartnicka, A.; Łukaszewicz, Z.; Krukow, P.; Morylowska-Topolska, J.; Skonieczna-Zydecka, K.; Krajka, T.; Jonak, K.; et al. The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls. Nutrients 2018, 10, 548.

Tao et al. (2019): adolescent depressive disorder

In 186 adolescent patients with depressive disorder, a significantly higher rate of serum food antigen-specific IgG was found compared with the same number of healthy controls.

Source: Tao, R.; Fu, Z.; Xiao, L. Chronic Food Antigen-specific IgG-mediated Hypersensitivity Reaction as A Risk Factor for Adolescent Depressive Disorder. Genom. Proteom. Bioinform. 2019, 17, 183–189.

Questionnaire study

A questionnaire study involving 5,286 people reporting various chronic complaints evaluated the subjective effect of an elimination diet recommended on the basis of food-specific IgG ELISA results, three months after testing. Of those who strictly followed the dietary recommendations, 75.8% reported a noticeable improvement in their condition; in 68.2% of those who experienced improvement, the favourable change appeared within three weeks. Of the strictly adherent participants reporting at least three associated complaints/conditions, 81.5% reported improvement. Among those who experienced a high degree of improvement and strictly followed the diet, 92.3% reported a return of symptoms when the excluded foods were reintroduced.

Source: Hardman G, Hart G. Dietary advice based on food-specific IgG results. Nutrition & Food Science. 2007;37(1):16–23. DOI: 10.1108/00346650710726913.

Summary: the position of the FOODTEST.HU Food Intolerance Centre

Much of the professional debate on food-specific IgG testing stems from the fact that different immunological phenomena and different tests – in particular total IgG and IgG4 – are often placed in a single category. Based on the available data, therefore, neither the categorical rejection of IgG testing nor the interpretation of a positive IgG result as a stand-alone diagnosis can be considered a sufficiently nuanced approach.

What is worth distinguishing?

Food-specific total IgG testing is not a diagnostic tool for IgE-mediated food allergy, nor is it suitable for detecting non-immune-mediated intolerances – such as lactase deficiency. These continue to be investigated using appropriate, validated allergological, gastroenterological and functional diagnostic methods.

It is equally essential to distinguish between total IgG and IgG4. IgG4 may be associated with prolonged antigen exposure and immunological tolerance, and its complement-activating capacity is minimal. Total IgG, by contrast, measures the combined response of the IgG1–4 subclasses. For this reason, evidence rejecting the clinical use of IgG4 cannot automatically be regarded as data proving the clinical irrelevance of total IgG. At the same time, a large proportion of current professional position statements discuss IgG and IgG4 together, or rely on earlier consensus documents that relate mainly to IgG4.

What do clinical studies say?

As we have seen above, over the past two decades several studies in IBS, IBD, migraine and other patient populations have observed clinical improvement with elimination guided by food-specific IgG. The quality of the evidence, however, is heterogeneous: the early studies include many with small sample sizes, an open-label design or subjective endpoints.

More recent studies already include randomised, controlled and sham-controlled trials. Particularly noteworthy is the IBS trial published by Singh et al. in 2025, in which IgG-guided elimination produced a clinically relevant reduction in abdominal pain in a significantly higher proportion of patients than the sham diet.

What does a positive result mean?

A positive food-specific IgG result does not in itself indicate disease, nor does it prove that the given food is the cause of the patient's symptoms.

The result should therefore be treated not as an isolated laboratory diagnosis but – where appropriately indicated – as potential supplementary information within a comprehensive clinical evaluation.

Clinical evaluation must precede the test and the elimination: where necessary, IgE-mediated allergy, coeliac disease, IBD, infection, malabsorption, enzymatic intolerances and other organic or functional conditions, among others, must be ruled out.

Elimination is not the final destination

An IgG result does not justify the long-term, unmonitored exclusion of an unlimited number of foods. An overly restrictive diet can lead to nutrient deficiencies, reduced dietary diversity and unnecessary illness perception; in children this matters even more. FOODTEST's professional position is therefore that testing is not recommended under the age of 2, and that elimination in children should take place under paediatric/dietetic supervision.

Reintroduction is particularly important, because an improvement during elimination does not by itself confirm the clinical relevance of the IgG result. The reproducibility of the symptom–food relationship during reintroduction provides considerably stronger clinical information.

Food-specific total IgG is therefore not a marker of IgE-mediated allergy or of enzymatic intolerance, and its positivity is not in itself a diagnosis. At the same time, total IgG should not be equated with IgG4, and based on more recent intervention studies, the clinical usefulness of IgG-guided elimination in certain appropriately selected patient groups merits further investigation and, in some cases, can be considered as a therapeutic tool.

The key to safe use is not the laboratory result alone, but appropriate patient selection, differential diagnosis, a diet compiled by a professional, ensuring nutritional adequacy, documenting the symptom response and controlled reintroduction.

Book a food intolerance test

Food intolerance

Don't just get the school bag ready

Starting school is not only about new exercise books and a changed daily routine but also about reorganising family meals. The FOODTEST Children's pac...

Related articles